Celltrion to conduct tests on Omicron variant detected in Korea

Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...

Celltrion to export COVID-19 treatment to Europe in 2021

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

Brazil gives emergency use nod for Celltrion’s COVID-19 treatment

South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...

Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment

South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...

Celltrion’s COVID-19 treatment reduces incidence of severity by 70%

Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...